Santa Cruz Biotechnology delivers a wide array of EML2 monoclonal antibodies for research focused on understanding EML2 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EML2, or echinoderm microtubule-associated protein-like 2, regulates microtubule dynamics and plays a vital role in cellular processes such as mitosis and intracellular transport. The proper functioning of EML2 maintains cellular structure and facilitates cell division, making it particularly relevant in cancer research and developmental biology. Research has shown that EML2 dysregulation is associated with various pathological conditions. Understanding EML2's molecular mechanisms and cellular functions can provide valuable insights into disease development and potential therapeutic strategies. Investigating EML2's role in different biological pathways helps advance knowledge about cellular regulation and disease progression. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to scientific understanding of EML2-related cellular processes.